Cohesins and cohesin-regulators: Role in Chromosome Segregation/Repair and Potential in Tumorigenesis
Plasticity and Tumorigenicity
Vacuolar H(+)-ATPase in Cancer Cells: Structure and Function
Genes
FOXO4 (myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7) ANXA1 (annexin A1) ASNS (asparagine synthetase) ASPM (asp (abnormal spindle) homolog, microcephaly associated (Drosophila)) ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67)) ATF5 (activating transcription factor 5) ATM (ataxia telangiectasia mutated) ATR (ataxia telangiectasia and Rad3 related) BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ANXA1 (annexin A1) ASNS (asparagine synthetase) ASPM (asp (abnormal spindle) homolog, microcephaly associated (Drosophila)) ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67)) ATF5 (activating transcription factor 5) ATM (ataxia telangiectasia mutated) ATR (ataxia telangiectasia and Rad3 related) BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ASNS (asparagine synthetase) ASPM (asp (abnormal spindle) homolog, microcephaly associated (Drosophila)) ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67)) ATF5 (activating transcription factor 5) ATM (ataxia telangiectasia mutated) ATR (ataxia telangiectasia and Rad3 related) BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ASPM (asp (abnormal spindle) homolog, microcephaly associated (Drosophila)) ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67)) ATF5 (activating transcription factor 5) ATM (ataxia telangiectasia mutated) ATR (ataxia telangiectasia and Rad3 related) BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67)) ATF5 (activating transcription factor 5) ATM (ataxia telangiectasia mutated) ATR (ataxia telangiectasia and Rad3 related) BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ATF5 (activating transcription factor 5) ATM (ataxia telangiectasia mutated) ATR (ataxia telangiectasia and Rad3 related) BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ATM (ataxia telangiectasia mutated) ATR (ataxia telangiectasia and Rad3 related) BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ATR (ataxia telangiectasia and Rad3 related) BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BCAR1 (breast cancer anti-estrogen resistance 1) BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BCL6 (B-Cell Lymphoma 6) BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BEX1 (brain expressed, X-linked 1) BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BEX2 (brain expressed X-linked 2) BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BRCA2 (breast cancer 2, early onset) BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BRE (brain and reproductive organ-expressed (TNFRSF1A modulator)) BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BUB1B (budding uninhibited by benzimidazoles 1 homolog beta (yeast)) BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
BUB1 (budding uninhibited by benzimidazoles 1 homolog (yeast)) CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CCNA1 (cyclin A1) CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CDK20 (cell cycle related kinase) CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CDK4 (cyclin-dependent kinase 4) CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CDKN1B (cyclin-dependent kinase inhibitor 1 B) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CDKN2A (cyclin dependent kinase 2a / p16) CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CDKN2A (cyclin dependent kinase 2a / p16) CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CDKN2B (cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)) CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CHKA (choline kinase alpha) CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CKS1B (CDC28 protein kinase regulatory subunit 1B) CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CKS2 (CDC28 protein kinase regulatory subunit 2) CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CLIC1 (chloride intracellular channel 1) CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CLSPN (claspin) COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
COL16A1 (collagen, type XVI, alpha 1) COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CRK (v-crk sarcoma virus CT10 oncogene homolog (avian)) CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CSNK1A1 (casein kinase 1, alpha 1) CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CUX1 (cut-like homeobox 1) CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CXCL10 (chemokine (C-X-C motif) ligand 10) CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
CYLD (cylindromatosis (turban tumor syndrome)) DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
DDR1 (discoidin domain receptor tyrosine kinase 1) DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
DDX5 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5) DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
DIRAS3 (DIRAS family, GTP-binding RAS-like 3) DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
DLX4 (distal-less homeobox 4) DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
DPP4 (dipeptidyl-peptidase 4) DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
E2F4 (E2F transcription factor 4, p107/p130-binding) ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ECT2 (epithelial cell transforming sequence 2 oncogene) EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
EIF3A (eukaryotic translation initiation factor 3, subunit A) EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
EPS8 (epidermal growth factor receptor pathway substrate 8) ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)) FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
FBXO31 (F-box protein 31) FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
FGF2 (fibroblast growth factor 2 (basic)) FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
FOSL1 (FOS-like antigen 1) FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
FOXF1 (forkhead box F1) FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
FOXM1 (forkhead box M1) FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
FPR1 (formyl peptide receptor 1) FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
FXYD3 (FXYD domain containing ion transport regulator 3) GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
GAS5 (growth arrest-specific 5 (non-protein coding)) GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
GFI1B (growth factor independent 1B transcription repressor) GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
GFI1 (growth factor independent 1 transcription repressor) GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
GSK3B (glycogen synthase kinase 3 beta) HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
SPECC1 (sperm antigen HCMOGT-1) HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
HIPK2 (homeodomain interacting protein kinase 2) HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
HMGA2 (high mobility group AT-hook 2) HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
HUS1 (HUS1 checkpoint homolog (S. pombe)) ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
ING4 (inhibitor of growth family, member 4) JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
JUNB (jun B proto-oncogene) JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
JUND (jun D proto-oncogene) KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
KIAA0101 (KIAA0101) KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
KSR1 (kinase suppressor of ras 1) LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
LGALS3 (lectin, galactoside-binding, soluble, 3) LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
LIMD1 (LIM domains containing 1) LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
LIMK1 (LIM domain kinase 1) LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
LZTS1 (leucine zipper, putative tumor suppressor 1) MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MACROD1 (MACRO domain containing 1) MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MAP2 (microtubule-associated protein 2) MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MAPK6 (mitogen-activated protein kinase 6) MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MARCKS (myristoylated alanine-rich protein kinase C substrate) MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MCM5 (minichromosome maintenance complex component 5) MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MCPH1 (microcephalin 1) MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MED28 (mediator complex subunit 28) MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MELK (maternal embryonic leucine zipper kinase) MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MINA (MYC induced nuclear antigen) MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MIR100 (microRNA 100) MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MIR191 (microRNA 191) MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MIR200C (microRNA 200c) MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MIR449A (microRNA 449a) MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MYBBP1A (MYB binding protein (P160) 1a) MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
MYEOV (myeloma overexpressed (in a subset of t (11;14) positive multiple myelomas)) NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
NAMPT (nicotinamide phosphoribosyltransferase) NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
NDRG1 (N-myc downstream regulated 1) NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
NPY1R (neuropeptide Y receptor Y1) NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PA2G4 (proliferation-associated 2G4, 38kDa) PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PCNA (proliferating cell nuclear antigen) PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PLCD1 (phospholipase C, delta 1) PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PML (Promyelocytic leukemia) PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
PTPN6 (protein tyrosine phosphatase, non-receptor type 6) RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RAD9A (RAD9 homolog A (S. pombe)) RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RANBP9 (RAN binding protein 9) RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RAN (RAN, member RAS oncogene family) RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RARRES3 (retinoic acid receptor responder (tazarotene induced) 3) RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RASSF5 (Ras association (RalGDS/AF-6) domain family member 5) RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RBBP8 (retinoblastoma binding protein 8) RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RBX1 (ring-box 1) REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
REST (RE1-silencing transcription factor) RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RHOC (ras homolog gene family, member C) RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RPA2 (replication protein A2, 32kDa) RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RPL26 (ribosomal protein L26) RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RPRM (reprimo, TP53 dependent G2 arrest mediator candidate) RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)
RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1)